P-48 EVALUATION OF IL-1β AND IL-1RA IN PATIENTS WITH CHRONIC LIVER DISEASES
Abigail Hernandez-Barragan1, Z. Medina-Avila1, D. Montes-de-Oca-Angeles1, M. Lemus-Peña1, M. Hernandez-Santillan1, M. Martínez-Castillo1, J.L. Pérez-Hernández2, F. Higuera-De la Tijera2, D. Santana-Vargas2, E. Montalvo-Jave2, P. Cordero-Pérez3, L. Muñoz-Espinosa3, J. Córdova-Gallardo4, A. Torre-Delgadillo5, D. Kershenobich5, G. Gutiérrez-Reyes1
1 Liver, Pancreas and Motility Laboratory, Unit of Research in Experimental Medicine, School of Medicine, Autonomy University of Mexico (UNAM), General Hospital of Mexico, Mexico City, Mexico
2 Departament of Gastroenterology, General Hospital of Mexico “Dr. Eduardo Liceaga,” Mexico City, Mexico
3 University Hospital “Dr. José Eleuterio González”, School of Medicine, Autonomy University of Nuevo León (UANL), Nuevo Leon, Mexico
4 General Hospital “Dr. Manuel Gea González”, Mexico City, México
5 National Institute of Medical Sciences and Nutrition “Salvador Zubirán,” Mexico City, México
Read
913
Timeswas read the article
180
Total PDF
733
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 19 | 3 | 22 |
| 2025 11 | 55 | 22 | 77 |
| 2025 10 | 31 | 10 | 41 |
| 2025 9 | 28 | 17 | 45 |
| 2025 8 | 45 | 24 | 69 |
| 2025 7 | 45 | 11 | 56 |
| 2025 6 | 45 | 5 | 50 |
| 2025 5 | 39 | 3 | 42 |
| 2025 4 | 25 | 4 | 29 |
| 2025 3 | 45 | 5 | 50 |
| 2025 2 | 34 | 3 | 37 |
| 2025 1 | 43 | 8 | 51 |
| 2024 12 | 29 | 1 | 30 |
| 2024 11 | 52 | 2 | 54 |
| 2024 10 | 23 | 2 | 25 |
| 2024 9 | 23 | 3 | 26 |
| 2024 8 | 34 | 6 | 40 |
| 2024 7 | 18 | 0 | 18 |
| 2024 6 | 17 | 1 | 18 |
| 2024 5 | 20 | 1 | 21 |
| 2024 4 | 27 | 2 | 29 |
| 2024 3 | 8 | 3 | 11 |
| 2024 2 | 4 | 5 | 9 |
| 2024 1 | 6 | 5 | 11 |
| 2023 12 | 2 | 5 | 7 |
| 2023 11 | 4 | 4 | 8 |
| 2023 10 | 4 | 8 | 12 |
| 2023 9 | 1 | 5 | 6 |
| 2023 8 | 3 | 3 | 6 |
| 2023 7 | 1 | 4 | 5 |
| 2023 6 | 2 | 4 | 6 |
| 2023 5 | 1 | 1 | 2 |
Show all
